US Market For OTC COVID-19 Tests Transitions From Unmet Demand To Multiple Choices
Executive Summary
Abbott’s’s distribution of its BinaxNOW COVID-19 Ag Self Test to US retailers increases to three the number of OTC tests for the virus that CVS offers, along with Ellume’s and Labcorp’s test kits also available under EUAs granted by FDA.
You may also be interested in...
Herbal Sprays, Nasal Swabs Latest Additions On List Of Fraudulent COVID Cures Offered In US
“Germaphobe’s Delight Spray” was “re-vamped … to better meet the challenges of COVID-19,” Fopo Jordan’s Crossing Herbal claimed. Halodine LLC claimed its nasal sanitizer “kills SARS-CoV-2 (the virus that causes COVID-19) in less than 15 seconds.”
COVID-19 Test Kit’s Use Of US FDA Logo With ‘Clinical Trial Number’ Fails Regulatory Test
Anytime COVID Test marketed home-use test without FDA approval or EUA and promoted it with an FDA logo and a “clinical trial number.” Warning letter says “your presentation conveys the misimpression that the product has been approved, cleared, authorized, endorsed or otherwise evaluated by FDA.”
OTC COVID-19 Tests Have Abbott Seeing Continuing Demand For At-Home Diagnostics
“We see this is a as a significant opportunity, and quite frankly, a trend that's been happening overseas and is kind of now happening here in the US,” says Abbott Labs CEO Robert Ford.